Skip to main navigation Skip to search Skip to main content

Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis

  • Jennifer Rossdale
  • , John Graby
  • , Maredudd Harris
  • , Calum Jones
  • , Davyd Greenish
  • , Jessica Bartlett
  • , Andrew Gilroy
  • , Jamie Sanghera
  • , John D. Pauling
  • , Sarah Skeoch
  • , Victoria Flower
  • , Rob Mackenzie Ross
  • , Jay Suntharalingam
  • , Jonathan C.L. Rodrigues
  • Respiratory Department
  • Royal United Hospitals Bath NHS Foundation Trust
  • Centre for Therapeutic Innovation University of Bath
  • Royal National Hospital for Rheumatic Diseases
  • Department of Rheumatology
  • North Bristol NHS Trust

Research output: Contribution to journal › Article › peer-review

5   Link opens in a new tab Citations (SciVal)

Abstract

Objective: Coronary artery calcification assessed on thoracic computed tomography represents the calcific component of established coronary artery disease, is a biomarker of total atheromatous plaque burden and predicts mortality. Systemic sclerosis is a pro-inflammatory condition, and inflammation is also a driver of coronary artery disease. We assessed coronary artery calcification prevalence, mortality risk and potential clinical impact on primary prevention in a cohort of patients with systemic sclerosis, differentiated by clinical phenotype including the presence of interstitial lung disease and pulmonary arterial hypertension. 

Methods: Retrospective analysis of 258 computed tomographies in systemic sclerosis patients from three prospectively maintained clinical and research databases at a single tertiary rheumatology/pulmonary hypertension (PH) service between March 2007 and September 2020 (mean age = 65 ± 12, 14% male). Co-morbidities, statin prescription and all-cause mortality were recorded. Patients were subtyped according to underlying systemic sclerosis complications. Computed tomographies were re-reviewed for coronary artery calcification; severity was graded using a 4-point scale per vessel and summed for total coronary artery calcification score. The impact of reporting coronary artery calcification was assessed against pre-existing statin prescriptions. 

Results: Coronary artery calcification was present in 58% (149/258). Coronary artery calcification was more prevalent in systemic sclerosis-pulmonary arterial hypertension than in systemic sclerosis subgroups with interstitial lung disease or without pulmonary arterial hypertension, controlling for age, sex, co-morbidities and smoking status (71%; χ2(13) = 81.4; p < 0.001). The presence and severity of coronary artery calcification were associated with increased risk of mortality independently of age and co-morbidities (hazard ratio = 2.8; 95% confidence interval = 1.2–6.6; p = 0.018). The ‘number needed to report’ coronary artery calcification presence to potentially impact management was 3. 

Conclusions: Coronary artery calcification is common in systemic sclerosis. Coronary artery calcification predicts mortality independently of age and confounding co-morbidities which suggests this finding has clinical relevance and is a potential target for screening and therapeutic intervention.

Original languageEnglish
Pages (from-to)192-202
Number of pages11
JournalJournal of Scleroderma and Related Disorders
Volume9
Issue number3
Early online date11 Aug 2024
DOIs
Publication statusPublished - 1 Oct 2024

Data Availability Statement

The data underlying this article are available from the corresponding author upon reasonable request.

Keywords

  • Cardiovascular
  • coronary artery calcification
  • coronary artery disease
  • imaging
  • interstitial lung disease
  • pulmonary arterial hypertension

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Fingerprint

Dive into the research topics of 'Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis'. Together they form a unique fingerprint.

Cite this